Progyny (PGNY) Revenue (2018 - 2026)

Progyny (PGNY) has 9 years of Revenue data on file, last reported at $328.5 million in Q1 2026.

• On a quarterly basis, Revenue rose 1.38% year-over-year to $328.5 million in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 6.59% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 10.4% from the prior year.
• Revenue for Q1 2026 stood at $328.5 million, up from $318.4 million in the prior quarter.
• Over the last five years, Revenue for PGNY reached as high as $332.9 million in Q2 2025 and fell as low as $172.2 million in Q1 2022.
• Historically, Revenue has averaged $274.1 million across 5 years, with a median of $280.9 million in 2023.
• Across the five-year window, Revenue jumped 68.03% in 2022 and grew 1.38% in 2026, its largest moves.
• Year by year, Revenue stood at $214.3 million in 2022, then grew by 25.95% to $269.9 million in 2023, then advanced by 10.55% to $298.4 million in 2024, then gained by 6.69% to $318.4 million in 2025, then increased by 3.17% to $328.5 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $328.5 million in Q1 2026, $318.4 million in Q4 2025, and $313.3 million in Q3 2025.